Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07403552
PHASE1
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
Sponsor: Ensho Therapeutics, Inc.
View on ClinicalTrials.gov
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of NSHO-101 in Healthy Participants.
Official title: A Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-01-31
Completion Date
2026-06
Last Updated
2026-02-11
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
NSHO-101
Dose form - tablet Route of administration - oral Regimen / Treatment period - QD for 14 days
Locations (1)
Cenexel Anaheim CA
Anaheim, California, United States